13D Filing: TPG Group Holdings (SBS) Advisors, Inc. and Zimmer Biomet Holdings, Inc. (ZBH)

In a recent 13D filing with the Securities and Exchange Commission, TPG Group Holdings (SBS) Advisors reported a long position in Zimmer Biomet Holdings Inc (NYSE:ZBH). According to the filing, TPG Group owns around 7.35 million shares of Zimmer Biomet, which represent around 3.7% of the company’s outstanding stock.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
TPG Group Holdings (SBS) Advisors, Inc. 0 7,351,712 0 7,351,712 7,351,712 3.7%
David Bonderman 0 7,351,712 0 7,351,712 7,351,712 3.7%
James G. Coulter 0 7,351,712 0 7,351,712 7,351,712 3.7%

Page 1 of 11 SEC Filing

SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13D
(Amendment No. 1)

 

Zimmer Biomet Holdings, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
98956P102
(CUSIP Number)

Clive
Bode

Vice
President

TPG
Global, LLC

301
Commerce Street, Suite 3300

Fort
Worth, TX 76102

(817)
871-4000

(Name,
Address and Telephone Number of Person

Authorized
to Receive Notices and Communications)

February 4, 2016
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box. ☐;

Note.
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7
for other parties to whom copies are to be sent.

(Continued on following pages)

(Page 1 of 11 Pages)

______________________

* The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Zimmer Biomet Holdings Inc. (NYSE:ZBH)